Position in RPRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$22,086,778
+$8,013,049 QoQ
Shares Held
460,429
+26.4% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. RPRX ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,086,778 | 460,429 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $14,073,729 | 364,227 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,941,856 | 253,454 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $13,918,280 | 386,297 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $10,393,994 | 333,890 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,107,961 | 357,035 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,951,320 | 528,502 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,683,266 | 594,739 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $14,329,870 | 471,843 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $9,213,321 | 327,993 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,576,210 | 279,153 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $7,579,653 | 246,573 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,195,141 | 171,944 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,062,813 | 102,804 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,953,509 | 123,283 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,808,954 | 114,390 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,997,774 | 153,947 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,658,184 | 116,893 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,718,365 | 130,558 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,822,268 | 117,645 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $7,211,911 | 165,335 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,022,018 | 60,380 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,591,338 | 37,826 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,710 | 200 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||